 WOODSTOCK, Ga.--BUSINESS WIRE--Sonoma Pharmaceuticals, Inc. Nasdaq: SNOA, a global healthcare leader developing and producing stabilized hypochlorous acid HOCl products for a wide range of applications, including wound care, eye care, nasal care, oral care, disinfectant use and dermatological conditions, and Microderm Technologies Ltd. announce that Dermodacyn disinfectant has received import clearance as a medical device for Thailand with the help from Microderms partner VetSynova Co. 